MD Anderson, AstraZeneca enter collaboration to help improve patient outcomes in ovarian and gynecologic cancers

The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news